FOLD FY 2025 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$634M+20.0% YoY

Gross Profit

$554M87.3% margin

Operating Income

$34M5.4% margin

Net Income

-$27M-4.3% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$30M

Stock-Based Comp.

$87M

Balance Sheet

Total Assets

$950M

Total Liabilities

$676M

Stockholders' Equity

$274M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$634M	$528M	+20.0%
Gross Profit	$554M	$475M	+16.5%
Operating Income	$34M	$25M	+38.7%
Net Income	-$27M	-$56M	+51.7%